Immunogenic proteins and compositions

Details for Australian Patent Application No. 2011219524 (hide)

Owner Novartis AG

Inventors Maione, Domenico; Rinuado, Daniela

Agent FB Rice

Pub. Number AU-A-2011219524

PCT Pub. Number WO2011/104632

Priority 1003333.0 26.02.10 GB

Filing date 28 February 2011

Wipo publication date 1 September 2011

International Classifications

C07K 14/315 Peptides having more than 20 amino acids

A61K 39/09 Medicinal preparations containing antigens or antibodies - Streptococcus

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/104632 Priority application(s): WO2011/104632

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011219529-Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same

2011219496-Anti-alpha2 integrin antibodies and their uses